Platinum Equity successfully takes over Lonza’s Water Care business

By Nikita Chaurasia  Date: 2019-03-03

Platinum Equity successfully takes over Lonza’s Water Care business
  • The divesture has been valued at USD 630 million.
     
  • Lonza will reinvest some of the transactional proceeds in the Healthcare Continuum.

Reputed global investment firm Platinum Equity has apparently made it to the headlines for having added a major business segment to its acquisition portfolio. If reports are to be believed, the company has declared that it has successfully completed the buyout of integrated solutions provider, Lonza’s water care business.

As per sources familiar with the knowledge of the matter, the divesture of Lonza’s water care business has been sealed in a transaction worth USD 630 million, approximately. Post the ownership transfer and the transition to being a standalone firm, Lonza’s water care business will generate a new corporate identity, the details of which will be unveiled a few months later. Reliable sources affirm that there are no changes on the cards with respect to the firm’s underlying consumer product brands.

Credible reports cite that the strategic agreement between the Lonza Group and Platinum Equity had already been announced back in November 2018. According to an official press release by Lonza, the company aims to reinvest a part of the transaction worth of the water care business in the Healthcare Continuum®. The deleveraging will continue to take place as pre-communicated, claims the release.

Incidentally, Lonza, earlier in the week, had already revealed the internal alignment of its business structure.

For the uninitiated, Lonza Group’s water care business is known to be a leading provider of highly innovative water treatment solutions. Reportedly, the firm successfully runs around six manufacturing facilities spanning the economies of EMEA, South America, and North America, and endorses sales locations in all major geographies across the globe. Trusted reports affirm that the water care business features some of the top-notch brands across the residential pool care market and pivotal positions in some of the high-growth industrial water care verticals.

An official statement by the leading private equity firm Platinum Equity claims that the company believes Lonza’s water care business to be a strong growth platform, owing to its market position and excellent track record for innovation.

For the record, Private Equity had been legally advised by Gibson, Dunn & Crutcher LLP for the acquisition of Lonza Group’s water care business.

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

France might ban short domestic flights to reduce its carbon footprint

France might ban short domestic flights to reduce its carbon footprint

By Nikita Chaurasia

French lawmakers recently came to a unanimous decision to ban domestic flights for distances that can be covered by train in over two-and-a-half- hours. The country aims to impose these restrictions in an effort to reduce carbon emissions, even as th...

Kavak secures USD 485 million in funding, eyes Latin America expansion

Kavak secures USD 485 million in funding, eyes Latin America expansion

By Nikita Chaurasia

Kavak, a Mexico-based used-car platform, has reportedly reached a valuation of USD 4 billion after securing USD 485 million during a new funding round. This makes it the fastest-growing as well as the most valued company in Latin America. The latest...

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

By Nikita Chaurasia

Indian pharmaceutical company Zydus Cadila is reportedly seeking approval from DCGI (Drug Controller General of India) for its PegIFN (Pegylated Interferon Alpha-2b), a hepatitis C drug, to treat COVID-19 patients, after its third phase of clinical t...

LinkedIn confirms launch of a social audio platform to rival Clubhouse

LinkedIn confirms launch of a social audio platform to rival Clubhouse

By Nikita Chaurasia

LinkedIn, the popular employment-oriented online service, has confirmed that it is testing a social audio experience in its app which could offer users with better connectivity in their networks. Although several social media giants such as Twitter ...

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

By Nikita Chaurasia

Pfizer Inc., an American multinational pharmaceutical corporation, has recently announced to have started the early phase trials for its oral antiviral drug for Coronavirus. The company revealed that first phase trials of the experimental drug, PF-07...